- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Veradigm Inc. (MDRX)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
02/20/2026: MDRX (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $5.83
1 Year Target Price $5.83
| 1 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 535.79M USD | Price to earnings Ratio - | 1Y Target Price 5.83 |
Price to earnings Ratio - | 1Y Target Price 5.83 | ||
Volume (30-day avg) 3 | Beta 0.53 | 52 Weeks Range 3.00 - 6.00 | Updated Date 11/15/2025 |
52 Weeks Range 3.00 - 6.00 | Updated Date 11/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-02-27 | When - | Estimate 0.07 | Actual - |
Profitability
Profit Margin -14.7% | Operating Margin (TTM) 16.59% |
Management Effectiveness
Return on Assets (TTM) -0.62% | Return on Equity (TTM) -1.69% |
Valuation
Trailing PE - | Forward PE 15.17 | Enterprise Value 241120000 | Price to Sales(TTM) 0.88 |
Enterprise Value 241120000 | Price to Sales(TTM) 0.88 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA 4.13 | Shares Outstanding 108900000 | Shares Floating 81497489 |
Shares Outstanding 108900000 | Shares Floating 81497489 | ||
Percent Insiders 4.36 | Percent Institutions 40.99 |
Upturn AI SWOT
Veradigm Inc.

Company Overview
History and Background
Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.) has a long history in the health IT sector. It was founded in 1986. The company has undergone significant transformations, including mergers, acquisitions, and rebranding. A major milestone was the acquisition of various health IT assets and the subsequent rebranding to Veradigm to reflect its focus on digital health and data analytics. Its evolution reflects the broader trends in healthcare technology, moving from electronic health records (EHR) to more integrated data solutions.
Core Business Areas
- Veradigm EHR and Practice Management: Provides electronic health record (EHR) and practice management solutions to ambulatory physician practices, enabling clinical workflow, patient engagement, and revenue cycle management.
- Veradigm Data Solutions: Offers a suite of data analytics, population health management, and patient engagement tools that leverage aggregated and de-identified health data to improve outcomes and reduce costs. This includes data aggregation, insights, and research services.
- Veradigm Payment Solutions: Focuses on revenue cycle management services, helping healthcare providers optimize billing, coding, and claims processing to improve financial performance.
Leadership and Structure
Veradigm Inc. is led by a management team with experience in healthcare technology and business operations. The organizational structure is typically segmented by its core business areas, with dedicated teams for product development, sales, marketing, and customer support within each segment. Specific leadership roles and their responsibilities can be found on the company's investor relations website.
Top Products and Market Share
Key Offerings
- Veradigm EHR: A comprehensive electronic health record system designed for ambulatory physician practices. It supports clinical documentation, e-prescribing, order entry, and patient portals. Competitors include Epic Systems, Cerner (now Oracle Health), Athenahealth, and NextGen Healthcare. Market share is fragmented, but Veradigm is a significant player in the ambulatory EHR market.
- Veradigm Data & Analytics Platform: This platform aggregates data from various sources, including EHRs, to provide insights for population health management, clinical research, and payer analytics. Key competitors include Optum, Health Catalyst, and IBM Watson Health (though some parts have been divested). Veradigm aims to differentiate through its extensive network and the breadth of data it can access.
- Veradigm Patient Engagement Solutions: Includes patient portals, appointment scheduling tools, and secure messaging to enhance communication between patients and providers. Competitors include Zocdoc, Luma Health, and often integrated features within EHR systems from major players.
Market Dynamics
Industry Overview
The healthcare IT industry is characterized by rapid technological advancement, increasing regulatory scrutiny, and a growing demand for interoperability and data-driven insights. Key trends include the shift towards value-based care, the adoption of AI and machine learning, and the focus on patient experience and digital health. The industry is highly competitive with a mix of large established players and innovative startups.
Positioning
Veradigm positions itself as a key enabler of the modern digital healthcare ecosystem. Its competitive advantages lie in its extensive network of providers, its ability to aggregate and analyze diverse health data, and its integrated suite of solutions spanning EHR, data analytics, and payment solutions. The company aims to bridge the gap between clinical care, data utilization, and financial performance.
Total Addressable Market (TAM)
The TAM for health IT solutions is substantial and growing, encompassing EHRs, data analytics, population health management, patient engagement, and revenue cycle management. Estimates vary, but the global health IT market is projected to reach hundreds of billions of dollars in the coming years. Veradigm is positioned to capture a significant portion of this TAM by offering integrated solutions that address multiple facets of healthcare operations and data utilization.
Upturn SWOT Analysis
Strengths
- Extensive network of healthcare providers and a large patient data repository.
- Integrated suite of solutions covering EHR, data analytics, and revenue cycle management.
- Focus on interoperability and data-driven insights.
- Established relationships with payers and life sciences companies.
Weaknesses
- Past financial performance and operational challenges.
- Dependence on third-party partnerships for certain data access.
- Intense competition from larger, more well-capitalized players.
- Need for continuous innovation to keep pace with evolving technology.
Opportunities
- Growing demand for real-world evidence (RWE) in drug development and clinical research.
- Expansion into new markets and service offerings related to value-based care.
- Leveraging AI and machine learning to enhance data analytics capabilities.
- Strategic partnerships to expand reach and service offerings.
Threats
- Increasing cybersecurity risks and data privacy regulations (e.g., HIPAA).
- Changes in healthcare reimbursement policies and government regulations.
- Rapid technological advancements by competitors.
- Economic downturns impacting healthcare spending.
Competitors and Market Share
Key Competitors
- Epic Systems (EPIC)
- Oracle Health (formerly Cerner) (ORCL)
- Athenahealth (ATHENA)
- NextGen Healthcare (NXGN)
- Optum (part of UnitedHealth Group) (UNH)
- Health Catalyst (HCAT)
Competitive Landscape
Veradigm faces intense competition from large, established EHR vendors and specialized data analytics firms. Its advantages lie in its integrated approach and its extensive network for data aggregation. However, it often competes with companies that have larger R&D budgets and more established brand recognition in specific market segments. Differentiation through specialized data offerings and unique partnerships is key.
Growth Trajectory and Initiatives
Historical Growth: Veradigm has experienced periods of growth driven by acquisitions and expansion of its product and service offerings. However, it has also faced challenges in integrating acquisitions and achieving consistent organic growth in certain segments. The company's growth trajectory has been marked by strategic realignments to focus on its core strengths in data and digital health.
Future Projections: Future growth projections for Veradigm are likely tied to the increasing demand for data analytics in healthcare, the adoption of value-based care models, and its ability to secure new contracts with providers, payers, and life sciences companies. Analyst consensus, if available, would provide specific revenue and earnings growth estimates. Key growth drivers are expected to be its data solutions and participation in value-based care initiatives.
Recent Initiatives: Recent initiatives have focused on enhancing its data analytics platform, expanding its capabilities in real-world evidence generation, and strengthening its partnerships within the healthcare ecosystem. This includes efforts to improve data interoperability and provide actionable insights to stakeholders.
Summary
Veradigm Inc. operates in the dynamic health IT sector, with core strengths in EHR, data analytics, and revenue cycle management, supported by an extensive provider network. The company's ability to aggregate and analyze real-world health data presents significant opportunities, particularly in RWE for life sciences and value-based care initiatives. However, Veradigm faces stiff competition from larger players and must navigate evolving regulatory landscapes and cybersecurity threats. Continued investment in innovation and strategic partnerships are crucial for its future growth and competitive positioning.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (SEC: 10-K, 10-Q)
- Industry Research Reports
- Financial News Outlets
- Company Website
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data and market share figures are estimates and subject to change. Users should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Veradigm Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 1999-07-26 | CEO - | ||
Sector Healthcare | Industry Health Information Services | Full time employees 2450 | Website https://veradigm.com |
Full time employees 2450 | Website https://veradigm.com | ||
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 
